An interventional study of patient included in experimental groupe will view the video excerpt, a playtime, a drawing activities in Autism Spectrum Disorder (ASD), sponsored by Centre Hospitalier Intercommunal Robert Ballanger. Recruiting at 1 site in France. Open to participants aged 3 Years to 15 Years. Per ClinicalTrials.gov, last updated 2025-02-06.
Sponsored by Centre Hospitalier Intercommunal Robert Ballanger · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 50 studies in Autistic Disorder with a site in France — 10 open to participants now, 10 under way, 1 of them phase 3. Autistic Disorder · France.
Among the 50 studies in Autistic Disorder with a site in France, this one is the 31st largest by planned enrollment of the 37 interventional ones that give a count, is one of 5 that started in 2023, is one of 26 with no phase, and was the 45th registered.
1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.
Browse Autistic Disorder studies →10 of the 50 studies in Autistic Disorder with a site in France are open now. Recruiting first, the newest first:
Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Sites in France, United States, Australia and 8 more countries
Ages 5–17
University Hospital, Brest · Sites in France
Ages up to 24
University Hospital, Grenoble · Sites in France
Ages 18–50 · Healthy volunteers
University Hospital, Tours · Sites in France
Ages 18+ · Healthy volunteers
Institut National de la Santé Et de la Recherche Médicale, France · Sites in France
Ages 24 mo–70 yrs · Healthy volunteers
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.
This study: 3 Years to 15 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
50 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 5 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 50 across 814 interventional studies indexed under Autistic Disorder.
Median enrollment 60 across the 37 interventional studies, 103 across the 13 observational. Of the 32 that completed or were terminated, 4 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 50 have an industry lead sponsor. The 10 most frequent:
Centre Hospitalier Intercommunal Robert Ballanger is the lead sponsor of 6 studies on the registry; 4 are open to participants now.
Centre Hospitalier Intercommunal Robert Ballanger has 1 study filed under Autistic Disorder — fewer than ten, so there is no comparison to draw.
1 of the studies in Autistic Disorder with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06443320Centre Hospitalier Intercommunal Robert BallangerEvaluation of the Videodrama Therapeutic Device for Children with Autism Spectrum Disorders | 2027-03-04 |
Add it to your calendar (.ics) → With an account.
Among the 50 studies in Autistic Disorder with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Autism spectrum disorder (ASD) is a neurodevelopmental disorder (Valerie, Sperenza, 2009) that begins early in development, characterized by persistent deficits in communication and social interactions across various contexts and restricted, repetitive patterns of behavior, interests, or activities. These symptoms significantly impact social, school/professional functioning, or other important areas and are not better explained by intellectual disability or global developmental delay (American Psychiatric Association, 2013).
Currently, managing children with ASD emphasizes compensating for communication and social interaction disabilities. Communication tools like PECS or Makaton and social skills groups have shown effectiveness but have limitations, particularly not addressing sensory atypicalities seen in children with ASD. These sensory atypicalities are evident when children watch videos on screens. The idea is to use video to understand the sensory experiences of children with ASD and help them move away from an isolated relationship with screens. New technologies can further isolate children with ASD in their autistic sphere. The hypothesis is that observing these children with screens will provide better understanding of their sensory experiences and improve therapeutic support towards play and interaction with others
1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.
This study's planned enrollment of 30 is below the median of 50 across 814 interventional studies indexed under Autistic Disorder.
Browse Autistic Disorder studies →Centre Hospitalier Intercommunal Robert Ballanger is the lead sponsor of 6 studies on the registry; 4 are open to participants now.
Compared within Autistic Disorder, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Autism Spectrum Disorder. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Children participating in videodrama sessions, one per week for 9 sessions.
Other: patient included in experimental groupe will view the video excerpt, a playtime, a drawing activities
Patients included in the cohort will be managed as part of their routine care
Patients included in the videodrama arm will participate in a total of 18 videodrama sessions, with one session per week. Each session will include a patient welcome period, the viewing of a video excerpt (in slow motion or not), a playtime, a drawing period, and a group closing session. For the play and drawing activities, the same materials will be provided in each department and for each group, including small figurines, animals, shapes (such as cubes, triangles, circles), small plush toys, markers, colored pencils, and A4 white sheets of paper.
Dunn Sensory Profile questionnaire
Sensory atypicality frequency will be assessed using the Dunn Sensory Profile questionnaire, describing child behavior in various sensory experiences
Time frame: 9 months
Cars-T questionnaire
Observe improvements in social skills (interaction and communication) in children with ASD, assessed by the Cars-T questionnaire,
Time frame: 9 months
Sceno Test
Observation of the emergence of a symbolic game. This emergence will be evaluated by the passation of the scenotest, a test which reveals the different modalities of integration of the game.
Time frame: 9 months
Started Dec 2023 (actual). Primary completion is estimated for Mar 2027, 39 months after the start.
Of 355 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 39 months is above that.
Counting every sponsor, half of 367 studies reached it within 26 months; a quarter within 13 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Intercommunal Robert Ballanger